Day One

Explore challenges in delivering drugs to the olfactory region and trigeminal pathways with high precision

• Review strategies to navigate the nasal cavity for consistent CNS targeting
• Case studies highlighting successful intranasal delivery
• Current models to test olfactory delivery where are the gaps and the innovations?

• Explore emerging formulation and device strategies that increase direct brain uptake of drugs and biologics
• Understand approaches to minimize systemic exposure while maximizing CNS delivery for better efficacy and safety
• Gain insights into experimental and translational methods that can accelerate the development of CNS-targeted therapies

The ideal opportunity to get face-to-face with many global nasal formulation and delivery leaders for important in-depth conversations.

• Understand the critical difference between producing batches for early studies versus large-scale commercial production.
• Learn how to assess partner capabilities, capital readiness and long-term vision to ensure they can support commercialization, not just development
• Explore strategies to align device design, manufacturing investment and regulatory timelines when capital and resources are constrained

• Review successes and failures in bringing intranasal drugs from concept to commercialization
• Examine strategies for driving adoption, demonstrating clinical value, and overcoming market inertia
• Learn practical tactics for optimizing launch timing, pricing, and market positioning

• Explore approaches to solubilize and stabilize small molecules, biologics, and nucleic acids within limited nasal volumes
• Understand how viscosity and excipient selection impact dissolution, absorption, and formulation performance
• Discuss formulation design strategies to maximise therapeutic levels while maintaining patient safety

• Examine strategies to modulate mucoadhesion and overcome rapid clearance by the nasal mucosa
• Explore delivery approaches to optimize deposition and retention in target regions of the nasal cavity
• Learn how formulation-device integration can improve residence time and therapeutic outcomes

Witness some of the latest and greatest research in the nasal drug development & delivery field by drug developers, academics, service providers, and researchers in this spotlight poster session!

• Explore the impact of various formulation attributes on CNS and inner ear targeting
• Understand challenges in low-dose delivery and strategies to prevent underdosing
• Case study examples from a unique nasal formulation and delivery relief to recent onset tinnitus

• Compare powder versus liquid intranasal delivery, highlighting how deeper nasal deposition, increased surface area, and richer vascular access can drive faster and higher systemic absorption
• Explore the critical challenges of particle size distribution, particle shape, and limited large-scale manufacturing capacity, and how proprietary formulation strategies can address them
• Advancing powder-based naloxone and epinephrine programs, including device considerations, scalability planning, and where innovation is still needed across delivery technologies and manufacturing infrastructure